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Summary
The aims of the Polish survey were to assess efficacy of screening for
depression in gynecological practice and to estimate prevalence of
depressive disorders in midlife women visiting gynecologists. The
study included 2262 female outpatients aged 45–55, who were
screened by 120 gynecologists throughout Poland. Patients completed
the Beck’s Depression Inventory (BDI) and were assessed by
gynecologists to verify the presence of symptoms of a current De-
pressive Episode according to ICD-10 diagnostic criteria. Patients
who obtained a score of 12 points or more on the BDI were referred
for psychiatric evaluation, including the modified version of Mini
International Neuropsychiatric Interview (MINI). The study showed
that gynecologists in Poland are able to perform screenings for
depression effectively in outpatient settings. Results also suggested that
about 19% of women aged 45 to 55 years visiting gynecologists may
suffer from depressive disorders.
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Introduction
Depression is among the most frequently encountered
psychiatric disorders in medical practice across different
specialties, including general medicine, neurology and
gynecology. Regardless of severity of symptoms, de-
pressive disorders affect about one-fifth of primary care
patients, but approximately half of those cases remain
undiagnosed and untreated (Cathebras et al., 1994; Coyne
et al., 1994; Sartorius et al., 1993; Sartorius et al., 1996;
Simon and VonKorff, 1995; Ustun and Sartorius, 1995).
The lifetime prevalence of depressive disorders in the
general population ranges from 5% to 17% (Bebbington
et al., 1998; Katon, 1987; Kessler et al., 1994; Robins and
Rieger, 1991); depression occurs about two times more
frequently in women than in men (Steiner and Yonkers,
1998; Stephenson-Cino et al., 1992).
Depression is regarded as a significant problem for
women not only in premenstrual or perinatal periods
(Bailey and Cohen, 1999; Braverman and Roux, 1978;
Cooper and Murray, 1998; Holcomb et al., 1996; Marcus
et al., 2003; Steiner, 1992; Steiner, 1998), but also dur-
ing menopause transition. Symptoms of depression are
confirmed by 10 to 30% of women aged 45–55 years
(Avis et al., 1994; Ballinger, 1990; Porter et al., 1996;
Stone and Pearlstein, 1994). Some studies found
increased incidence of depression even in the 5 years
preceding menopause (Ballinger, 1990; Schmidt et al.,
1997). Among women in this phase of life, depression is
two times more prevalent in women who report specific
complaints or symptoms and attend menopausal clinics
than in women who do not seek gynecological con-
sultation (Anderson et al., 1987; Hay et al., 1994;
Nicol-Smith, 1996). However, many studies found no
clear correlation between menopause and depression or
argue that clinical symptoms of depression might be
triggered or imitated by physiological signs of meno-
pausal transition (Bosworth et al., 2001; Dennerstein
et al., 1999; Kaufert et al., 1992; Matthews et al.,
1994; Nicol-Smith, 1996; Pearlstein et al., 1997). High
prevalence of perimenopausal depression was in most of
the studies associated with previous episodes of mood
disorders, which confirms the increased susceptibility to
develop depression during menopause in women with
recurrent depressive disorder (Avis et al., 1994; Hunter,
1990; Porter et al., 1996; Stone and Pearlstein, 1994).
Several hypotheses have been put forth to explain rela-
tionships between affective disorders and menopause.
Some theories postulate the significance of psychosocial
changes or personality problems in women in this phase
of life (Stone and Pearlstein, 1994; Vanwesenbeeck et al.,
2001). However, the primary role in women-specific
mood disorders is attributed to decreased activity of
estrogens in menopause transition (Birkhauser, 2002;
Dennerstein, 1987) and its impact on cerebral blood flow
(Maki and Resnick, 2000; Pines et al., 2002; Resnick
et al., 1998; Schmidt and Rubinow, 1997) as well as on
the function of different neurotransmitters, especially the
serotonergic system (Fink et al., 1996; Lippert et al.,
1996; Rubinow et al., 1998; Steiner and Pearlstein,
2000). The significance of disordered serotonergic func-
tion was confirmed indirectly by studies indicating the
effectiveness of serotonergic medications in the treatment
of menopausal depression (Goodnick et al., 2000).
Mild to moderate depressive states can be treated
successfully by primary care practitioners and other
non-psychiatrist physicians (Mulrow et al., 2000). How-
ever, most research has confirmed the high incidence of
unrecognized depressive disorders among patients in pri-
mary care (Schwenk et al., 1996) and in gynecological
practice (Marcus et al., 2003). Patients tend to dis-
close more depressive symptoms in self-report question-
naires than during clinical evaluation in direct contact
with physicians (Leung et al., 1998; Zich et al., 1990).
Therefore, using screening instruments could help to
diagnose patients presenting with symptoms of clinical
depression. Moreover, the screening procedure alone
may increase awareness of the possibility of depression
in patients seen by physicians who administer the ques-
tionnaire and may help in making early decisions to
initiate appropriate treatment.
Studies on screening for depression in midlife women
have not been performed in gynecological clinics in
Poland. The specific aims of our study were to evaluate
the feasibility of screening for depression by gynecolo-
gists within the standard practice of their clinics, and
to estimate the prevalence of depressive disorders in




The study was designed as a multicenter population study con-
ducted in both public and private outpatient gynecological clinics
in Poland. Gynecological clinics were selected from the official
database of gynecological outpatient clinics held by the Ministry
of Health and Social Care and the Polish Chamber of Physicians.
The entire database includes 3624 public and 1633 private out-
patient clinics. The final list of 120 clinics was drawn from the
database using a computer-generated randomization process. One
gynecologist from each randomized center was approached and
invited to participate in the study. At each study site, the gynecol-
ogist recruited 20 consecutive female patients aged 45 to 55 years
into the study. The described procedure was employed to ensure a
representative sample of Polish midlife female patients recruited
in gynecological out-patients clinics. The study took place from
May to October 2001. One-hundred-and-twenty gynecologists
and 40 consulting psychiatrists participated in the study. A total
of 2400 womenvisiting gynecologists were approached and asked
to participate in the study. After complete description of the study
to the subjects, written informed consent was obtained.
Procedures
The study was conducted in two major phases. First, all conse-
cutive female patients visiting gynecologists, regardless of nature
of complaint or reason for the visit, were approached and
informed about the study. Those women who agreed to partici-
pate were requested to complete the Polish version of the BDI
(Beck et al., 1961; Parnowski and Jernajczyk, 1977) while in the
waiting-room of the clinic. Next, during this visit, the gynecolo-
gist assessed the BDI score. Patients who scored 12 points or
more on the BDI (the cut-off point for depression in Poland;
(Parnowski and Jernajczyk, 1977) were evaluated by a gynecol-
ogist to confirm or rule out a preliminary diagnosis of depression.
ICD-10 criteria for symptoms of Depressive Episode (WHO,
1992) were used. Gynecologists also obtained a detailed medical
history for all patients. All women scoring 12 points or more on
the BDI were then referred for a psychiatric consultation. All
information was entered by gynecologists into a Clinical Record
Form. In the second phase of the study, patients scoring 12 points
or more on the BDI were referred to a psychiatric out-patient
clinic at a nearest location recommended by the gynecologist.
The patients were examined by a psychiatrist, who used the
modified Polish version of MINI (Sheehan et al., 1998), a
short-structured diagnostic interview based on the ICD-10 Clas-
sification that has been used to diagnose depressive disorders
in primary care, psychiatric clinics as well as gynecological
out-patient practices (Duburcq et al., 1999; Hsiao et al., 2002;
Kouakam et al., 2002). The final diagnosis of an affective disorder
was made by a psychiatrist based on clinical psychiatric exam-
ination. The psychiatrist also collected a history of previous
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episodes of psychiatric disorders and treatment received, and
made a decision about the need for current psychiatric treatment
(antidepressants or other medications) as well as a site for further
treatment (psychiatric hospital, psychiatric out-patient clinic,
primary care, gynecological clinic). All information regarding
the diagnosis of a psychiatric disorder, resulting from use of MINI
interview, and collected psychiatric history were entered into the
Clinical Record Form. The study was initiated after the formal
approval of the Bioethics Committee of the Medical University of
Warsaw for all participating centers, and ethical principles of the
Helsinki Declaration (updated in Edinburgh in 2000) were fol-
lowed. The study was supported by an unrestricted research grant
from Servier Polska and registered at the Central Register of
Clinical Research.
Analyses
In the statistical analysis, basic descriptive analyses of all stu-
died parameters were performed. Demographic and clinical data
were compared between ‘‘high BDI’’ (12 points or more of the
BDI score) and ‘‘low BDI’’ (less than 12 points on the BDI)
groups using chi-square tests for categorical variables (with
Yates’s corrections, when appropriate), t-tests for independent
samples for normally distributed continuous variables (with
Bonferroni corrections), and Mann-Whitney tests for continuous
variables when there was not a normal distribution (nonpara-
metric comparisons). Two-tailed tests with a 5% level of sig-
nificance were used throughout the analyses. All analyses were
conducted using SPSS-PC (Norusis, 1994).
In order to estimate the frequency of diagnosis of a depressive
disorder in the entire studied population of women, approxima-
tion analysis using the Monte-Carlo method was performed.
Computer software used techniques of random simulation to
assess the probability of a diagnosis of depression occurring in
the subgroup of patients who were not evaluated by psychia-
trists. The group of patients that was diagnosed by the psychia-
trists was divided into smaller groups according to 6 intervals of
BDI scores (12–15; 16–20; 21–25; 26–30; 31–35; >35). For
each small group, the probability of a diagnosis of depression
was calculated, and then values of that probability were applied
to respective intervals of BDI scores in the group not diagnosed
by psychiatrist. Finally, for the latter group, the total probability
of a diagnosis of depression was calculated.
This method attempts to extrapolate the probability of diag-
nosis of depression to the women not evaluated by psychiatrist.
Therefore, it is only an estimation of the likelihood of depres-
sion found in these women, and may well over- or underestimate
the real prevalence of depression in the whole study sample, so
the results should be interpreted cautiously.
Results
Of the 2400 women asked to participate in the study,
2262 women (94.3%) 45 to 55 years of age agreed to be
included in the study and filled out the BDI scale. The
mean age for the study sample was 49.85 3.09 years.
In the first phase of the study, 734 patients (32.5%)
achieved a score of 12 points or more on the BDI (‘‘high
BDI’’ group), and 1528 women (67.5%) scored less than
12 points (‘‘low BDI’’ group). The average BDI score
was 21.4 19.0 in the former group and 6.0 6.0 in the
latter (p<0.01). The mean ages in both groups were
comparable.
Gynecologists who participated in the study reported
that 38.2% of their patients with high BDI scores
seemed to be depressed at the time of assessment. How-
ever, after careful verification of ICD-10 basic criteria
for Depressive Episode, gynecologists found depressed
mood in 62% of patients with high BDI scores, loss
of interests and ability to feel pleasure in 55% of these
patients, and loss of energy or fatigue in 68% of these
subjects. Sixty-two percent of patients with high BDI
scores (442 of 714) were assessed by gynecologists to
have symptoms of depression according to ICD-10 cri-
teria for Depressive Episode.
Current somatic complaints were the primary reason for
the visit of 444 patients (60.5%) in the high BDI group and
of 500 women (32.7%) in the low BDI group (Table 1).
Among other reasons for the visit were: regular yearly
gynecological assessment, cytological examination, a need
for medication, and a need for a change in medication.
Most women in the high BDI group reported mul-
tiple menopausal complaints, as shown in Table 2. The
most frequently described symptoms included: heart pal-
pitations, night sweats, hot flashes, joint pains, vaginal
Table 1. Presenting problems of women aged 45–55 years visiting gynecologists by low BDI scores (BDI
<12) and high BDI scores (BDI score  12)
Main reason of the visit BDI <12 BDI  12 p
n¼ 1528 n¼ 734
% %
Control gynecological assessment 80.6 76.0 0.02
Current somatic complaints 32.7 60.5 
A need for medication or a need of change of medication taken 30.3 21.7 
Cytological examination 8.0 6.2 n.s.
Chi-square test,  p<0.01; n.s. – not significant.
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dryness, skin atrophy. Women in the low BDI group
reported such complaints significantly less frequently.
As can be seen in Table 3, women in the high BDI
group had significantly more pregnancies than those in
the low BDI group. There was also a significant differ-
ence in duration of menopausal symptoms: women with
high BDI scores reported such symptoms lasting more
than half a year longer than those with low BDI scores.
The duration of hormone replacement therapy (HRT) as
well as the time since the beginning of HRT to the relief
of menopausal symptoms was not different between the
two groups.
Gynecological history data are presented in Table 4.
The high BDI group of patients reported symptoms of
premenstrual syndrome, abortions and complications
during pregnancy and the perinatal period more fre-
quently than women with low BDI scores. Females with
high BDI scores more often experienced depression dur-
ing pregnancy, postpartum blues and postpartum depres-
sion or psychosis than women with low scores. There
were no differences in the number of miscarriages or
childbirths between the groups.
Patients in the high BDI group experienced more
gynecological surgeries in the past. Among the surgical
procedures, hysterectomy or mastectomy due to cancer
was reported significantly more often by the women in
the high BDI group, whereas females with low scores
reported more dilation and curettage procedures. In the
high BDI group, breast diseases were more often noted,
among them fibrocystic mastopathy (benign breast pro-
liferation – 25%), non-malignant nodules (20%), cystic
breast disease (14%) and breast cancer (8%). There were
no significant differences in the frequency of hormonal
contraceptive treatment or the frequency of depressed
mood associated with such therapy. More than half of
the females in both groups received HRT. No differences
were found between the number of women on HRT in
each group or the type of hormonal medication adminis-
tered. However, women in the low BDI group more
often evaluated HRT as an effective therapy.
The most common medical disorders found in these
patients are presented in Table 5. As can be seen from
the table, hypertension, ischemic heart disease, hypo-
thyroidism, other diseases of the thyroid gland (hyper-
thyroidism, non-toxic thyromegaly and thyroid nodules),
and diabetes were the most frequently reported diseases.
There were no differences between the two groups of
women in the frequency of somatic disorders.
Patients with high BDI scores visited their gynecolo-
gists significantly more frequently during the year pre-
ceding the study (on average of 3 times a year compared
with 2 times by patients with low BDI scores). As shown
in Table 6, women with high BDI scores also reported
difficult, stressful events (i.e., death of a close person,
job loss, financial loss, family conflict, divorce, chil-
dren’s leaving, etc.) more frequently during the last 6
months prior to their current visit and confirmed either a
diagnosis of depression in the past or previous psychia-
tric treatment. Almost 14% of gynecologic patients aged
45–55 years who scored 12 points or more on the BDI
were currently treated by psychiatrists at the time of
the study. Females with high BDI scores also had sig-
nificantly higher rates of family history of depression
than patients without depressive symptoms. In addition,
depression occurred more frequently in mothers (47%)
and sisters (20%) of patients, while fathers and brothers
rarely sufferedfromdepression (8%and4%,respectively).
Table 2. Menopausal somatic symptoms in women enrolled in the study
Complaints reported BDI <12 BDI  12 p
n¼ 1528 n¼ 734
% %
Any menopausal symptom 93.9 99.7 
Heart palpitations 33.4 64.7 
Night sweats 28.1 57.8 
Hot flashes 31.3 55.3 
Joint pains 35.3 56.4 
Vaginal dryness or painfulness 21.1 34.3 
Skin atrophy 16.0 25.5 
Mammary gland atrophy 12.8 15.5 n.s.
Chi-square test;  p<0.01; n.s. – not significant.






mean min–max median mean min–max median
Number of pregnancies 2.2 0–10 2 2.4 0–11 2 
Duration of climacteric symptoms (months) 15.3 0–324 6 21.6 0–144 12 
Duration of treatment with HRT (months) 18.7 0–132 12 17.7 1–96 12 n.s.
Time to relieve climacteric symptoms (months) 2.2 0–50 2 2.5 0–72 2 n.s.
Mann-Whitney test;  p<0.01; n.s. – not significant.
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In the second phase of the study, of the 734 women
with high BDI scores of 12 points or more who were
referred to a psychiatrist, only 317 (43.2%) came for a
consultation, while 417 females (56.8%) did not visit a
consulting psychiatrist. BDI scores in both subgroups
were significantly different (23.6 9.0 points for
women who came for a consultation, and 19.7 7.2
(p<0.01) for women who did not go to psychiatrist).
Psychiatrists diagnosed Depressive Episode (F32) in
33% of patients and Recurrent Depressive Disorder
(F33) in 30% of women who came in for a consultation.
Dysthymia was diagnosed in 13% of patients. Almost
one-fourth (24%) of these women were not given a diag-
nosis of a depressive disorder, however, in total, a diag-
nosis of an affective disorder (F32–F34) was assigned to
195 of 317 women (61.5%). Taking into account the 417
women who were not examined by psychiatrist, the total
estimated probability of a diagnosis of depression occur-
ring in women aged 45 to 55 years who scored 12 points
or more on BDI was calculated as 0.567. Thus, 236
subjects might be assigned a diagnosis of depression
among the 417 women who did not come to psychiatrist.
Therefore, 431 patients (58.7%) in the group of females
who scored high on BDI were estimated to have a
Depressive Disorder, which gives a proportion of
19.1% to the entire study population (N¼ 2262).
Based on clinical examination, consulting psychia-
trists recommended that 148 (76%) of 195 women with
a diagnosis of depression should be treated with antide-
pressant medication. Among those depressed females,
44% ought to be treated by psychiatrist, and 56% could
be treated for depression by their gynecologist.
Discussion
The study showed that gynecologists in Poland are
able to perform screening for depression effectively in
Table 4. Gynecological and obstetric history of women with low and high BDI scores
BDI <12 BDI  12 p
n¼ 1528 n¼ 734
% %
Premenstrual syndrome 47.8 56.4 
Miscarriages 20.6 22.3 n.s.
Abortions 9.2 12.7 0.02
Complications during pregnancies 17.1 23.2 
Complications during perinatal period 7.4 13.6 
Mood disorder during perinatal period 6.7 15.8 
Symptoms of depression during pregnancy 3.3 12.8 
Postpartum blues 12.5 23.6 
Postpartum major depression 2.3 10.3 
Postpartum psychosis 0.3 2.5 
Gynecological surgery in the past 44.4 54.1 
Breast diseases in the past 12.6 16.3 
Contraceptives use 22.6 21.1 n.s.
Mood disorders after contraceptives 9.6 15.5 n.s.
Hormone Replacement Therapy use 57.8 56.5 n.s.
Relieve of climacteric symptoms with HRT treatment 60.5 55.0 0.039
Chi-square test,  p<0.01; n.s. – not significant.
Table 5. Co-occurring medical disorders in women with low and high
BDI scores
Medical disorder BDI <12 BDI  12 p
n¼ 1528 n¼ 734
% %
Hypertension 21.9 26.8 n.s.
Coronary heart disease 7.0 10.4 n.s.
Diabetes 2.2 1.9 n.s.
Hypothyroidism 3.3 5.3 n.s.
Other thyroid gland disease 6.7 11.2 n.s.
Chi-square test, n.s. – not significant.
Table 6. Psychiatric history of women with low and high BDI scores
BDI <12 BDI  12 p
n¼ 1528 n¼ 734
% %
Stressful events in last 6 monthsa 16.9 35.9 
Diagnosis of depression in the past 4.8 21.5 
Psychiatric treatment in the past 4.8 23.0 
Current psychiatric treatment 3.3 13.5 
Family history of depression 5.8 14.0 
Chi-square test,  p<0.01.
a (e.g., death of a close person, job loss, financial loss, family conflict,
divorce, children’s leaving, etc.).
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outpatient settings. Gynecologists successfully screened
and attempted to make preliminary diagnoses of depres-
sion using ICD-10 diagnostic criteria for most (94%) of
visiting patients aged 45–55 years. Verification of
criteria for depressive episode by gynecologists revealed
almost the same proportion of depression in the group
with high BDI scores as assessed by psychiatrists. One
could assume then, that gynecologists in Poland were
able to more accurately diagnose depression according
to ICD-10 criteria in their patients than physicians in
other studies (Sartorius et al., 1993; Sartorius et al.,
1996; Ustun and Sartorius, 1995). In the WHO study,
primary-care practitioners diagnosed depression in only
2.8% of their patients while verification of the diagnosis
with standardized tools revealed a three times higher
prevalence of depression (8.7%). However, gynecolo-
gists in our study made only preliminary diagnoses of
depression and did not use validated diagnostic tools.
In the studied sample of midlife women, only 43%
who were referred actually came for a psychiatric con-
sultation. Presumably, women with more severe symp-
toms of depression came for evaluation by psychiatrists,
which was confirmed by the higher mean BDI score in
this subgroup. Most of those women who did not come
for psychiatric evaluation showed less prominent depres-
sive symptomatology (had lower BDI scores). The deci-
sion to visit a psychiatrist is very difficult in Poland,
because such a visit is still perceived as very stigmatiz-
ing in Polish culture, and thus most of the women in this
study did not come for assessment in psychiatric clinics.
Since many cases of depression in primary care remain
undetected (Sartorius et al., 1996; Simon and VonKorff,
1995), using a screening procedure for depression admi-
nistered by gynecologists could benefit at least those
outpatients with undiagnosed depression who visit gyne-
cological clinics.
Results of this study estimated that about 19% of
women aged 45 to 55 years visiting gynecological
clinics in Poland may suffer from depressive disorders.
Therefore, it can be assumed that one in five women at
that age who visit a gynecologist may experience symp-
toms of depression. Compared with findings from stu-
dies in similar populations of women, results of this
study indicate that Polish women may have lower levels
of depressive symptoms during menopause transition
than women in Western countries (Anderson et al.,
1987; Hay et al., 1994; Schmidt et al., 1997).
However, it is important to emphasize that, since more
than fifty percent of patients did not go for their referral
for a psychiatric consultation to verify a diagnosis of
depression, the proportion of females suffering from
depression in our study was estimated using a statistical
approximation method. This methodology may well
under- or overestimate the real prevalence of the disor-
der. We assumed that using BDI scores as intervals to
assess probability of depression among those women
who did or did not go for a psychiatric consultation is
the most reliable way of estimating total prevalence.
However, we did not evaluate depression in patients
who scored fewer than 12 points on the BDI, assuming
that the high positive predictive value of BDI as a
screening instrument justifies not sending those patients
for further assessment. Therefore, we do not have an
estimate of prevalence of depression in this group.
Moreover, extrapolating the prevalence of depression
from the group who visited psychiatrists (constituting
the most depressed patients based on their high BDI
scores) to the whole population of women aged 45–55
years visiting gynecologists may lead to overestimating
the prevalence of depression in the entire study sample.
Therefore, the generalizability of our results is very
limited and should be interpreted cautiously.
Women who scored high on the BDI visited their
gynecologists more frequently during previous year than
women with lower BDI scores. This finding corresponds
with results of other studies of primary-care patients
with and without symptoms of depression (Anderson
et al., 1987; Katon, 1987). In our study, females with
higher BDI scores not only experienced menopausal
symptoms about six months earlier than women with
low BDI scores, but they also reported these symptoms
significantly more frequently. These symptoms might
have led to their more intensive use of health services
in the past. Presumably, appropriate treatment of depres-
sion could decrease costs of health-care services utiliza-
tion in this group of patients.
Results of our study suggest that a thorough gyneco-
logical history is critical to assess the possibility of
depression in the period of menopause transition (Hay
et al., 1994; McKinlay et al., 1987; Porter et al., 1996;
Schmidt et al., 1997). High risk of depression may be
related to prior events such as premenstrual mood dis-
orders, greater number of pregnancies and abortions,
depressive episodes during pregnancy or postpartum
depression, stressful life events, familial burden of
depression, and co-occurring somatic diseases. Women
with depressive symptomatology in our sample experi-
enced more difficult, traumatic life events during the six
months preceding the current visit. This finding may
endorse the extant association between mood disorders
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and adverse life events (McKinlay et al., 1987), but it
may also result from a memory bias, since depressed
patients tend to remember and report more negative
events and stressful symptoms from the past than
non-depressed subjects. Recording stressful events as
well as most of symptoms in this study, although col-
lected by gynecologists, relied on self-reports of these
women. Such retrospective data could lead to a signifi-
cant recall bias, which should be considered as one of
the important limitations of our study.
Our study agrees with previous findings of possible
relationships between premenstrual and perinatal mood
disorders with a subsequent risk of depression in the
period of menopause transition (Hay et al., 1994;
McKinlay et al., 1987; Porter et al., 1996; Rubinow
et al., 1998; Schmidt et al., 1997). Subjects with high
BDI scores also more frequently reported a family his-
tory of depression, especially among female relatives.
This finding may indicate a potential genetic basis for
menopausal mood disorders, but again, it is based on
self-report data.
The studied sample entailed patients with a variety of
pre-existing medical disorders (e.g., thyroid disease) that
could produce both somatic and affective symptoms
reported by assessed women. Also, taking HRT by the
most of patients could contribute to the differences in
experiencing some somatic and emotional symptoms in
low and high BDI groups, and thus, even could influence
BDI scores. However, after stratification of the sample
by HRT treatment as well as presence of preexisting
medical disorders, all differences between the groups
remained significant, which indicates that the effect of
these potential confounders is minimal.
Research has thus far recognized possible associations
between hormonal and emotional disturbances in the
menopausal transition (Nicol-Smith, 1996; Rubinow
et al., 1998; Schmidt et al., 1997). In our study, female
patients with low or no depressive symptomatology (low
BDI group) evaluated the HRT therapy as more effective
and less frequently reported menopausal symptoms than
females with high BDI scores. This finding might sug-
gest that HRT not only alleviates somatic manifestations
of menopause, but also improves depressed mood at
least in some women. However, most clinical trials
showed only a modest influence of estrogens on symp-
toms of depression and they did not confirm direct anti-
depressant effects of hormonal treatment of menopause
(Stoppe and Doren, 2002).
This study estimated that one-fifth of women aged
45–55 years who visit gynecologists in Poland may suf-
fer from depression and presumably may seek help
primarily from gynecological clinics. According to the
opinions of the consulting psychiatrists, about 45% of
women with a diagnosis of depression had symptoms
severe enough to require further treatment by a psychia-
trist, while more than half of evaluated women with
depression could be treated by antidepressant therapy
prescribed by their gynecologists. This group of patients
needs special attention and presents a particular chal-
lenge for the treating physician. According to our
results, midlife women with more prominent depressive
symptomatology not only may have had more psychia-
tric, somatic or gynecological problems in the past, but
also, consequently, may report more menopausal symp-
toms during more frequent visits to gynecological
clinics.
The main limitation of our study derives from the
retrospective nature of the self-reported data which
might produce selective recall bias due to depression.
Also, the studied sample was not homogenous and cov-
ered a broad range of women in respect to their meno-
pause transition (i.e., premenopausal, perimenopausal
and postmenopausal), which makes it difficult to link
depressive symptoms with menopausal status. Moreover,
we lacked data on hormonal function of these patients.
In addition, assessment of the prevalence of depressive
disorders in these women is limited, since there is no
comparable epidemiological data on the prevalence of
depression in other age groups of women in Poland,
especially those attending outpatient gynecological
clinics. Our results are then limited only to this particu-
lar group of patients. Using the BDI as an indicator of
depression in menopausal women also has some restric-
tions. This instrument is a screening tool, and measures
severity of symptoms typical for depression. However,
most women in menopause transition report somatic and
emotional symptoms which may not be directly asso-
ciated with depression, but may contribute to higher
BDI scores. In our sample, 38% of patients with high
BDI scores had no confirmed diagnosis of depression.
Our study showed that gynecologists can effectively
provide screening for depressive disorders and, in addi-
tion, can approach diagnosing depression. Given the fact
that many women with symptoms of depression often do
not seek treatment from a psychiatrist, gynecologists and
other primary care physicians may be important sources
of care for these women. Gynecologists should be en-
couraged to use simple screening tools (e.g., BDI) in
high-risk patients to identify those women who require
diagnostic evaluation and treatment for depression
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(Concin et al., 2002; USPSTF, 2002). The low propor-
tion of depressive patients who came to psychiatrists for
consultation may indicate a fear of stigmatization and
this fact supports the need for intensive educational
programs designated not only for physicians of different
specialities, but also for women and their families.
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